Therabiopharma Inc. – Biotech research and development company with Kyoto University
- Company Name: Therabiopharma Inc.
- State/Prefecture: Kanagawa Prefecture
- City/Town/Village: Takatsu-ku, Kawasaki City
- Street: KSP Innovation Center, 3-2-1 Sakado
- Country: Japan
- Zip/Postal Code: 213-0012
- Phone: +81-44-322-0005
- Website: http://www.therabio.co.jp
- Contact: info@therabio.co.jp
- Listed: 08/23/2018 9:58 pm
- Expires: This ad has expired
Therabiopharma Inc. is a biotech research and development company under collaboration with Kyoto University in 2016. The company’s mission is to bring out potentials of natural materials and give new and different values to them and, through their transformation, to offer innovative products and technology that are able to meet the basic health needs of many people of all countries of the world.
Research and Development Fields
- Medicine
An anticancer drug: a world first water-soluble prodrug type curcumin injectable which can achieve the incomparable bioavailability as a free form of curcumin. - Diagnosis System
Fluorescent agent (curcumin) for the detection of submillimeter size tumors, contributing which are to very early stage of cancers. - Functional Material – Food
Development of functional materials from the nature with high bioavailability for supplements and food categories.
Ad Reference ID: 1555b7f636a921a2
Japanese Biotech Company Announces 10,000 Times Higher Curcumin Concentration in Bloodstream Clearly Demonstrates Strong Efficacies with/without Oxaliplatin for Colon Cancer
Date: Aug 21, 2018
KAWASAKI, Japan – Therabiopharma, a Japan based bio-venture, reports that CMG(Curcumin Monoglucuronide) has proven: 1. Same efficacy as Oxaliplatin for colon cancer without any adverse effects observed in Oxaliplatin treatment (Oxaliplatin is one of most frequently used colorectal cancer drugs worldwide).
Continue reading »